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Abstract 
Background: Low-grade hepatic encephalopathy (LGHE) comprises minimal hepatic encephalopathy (MHE) and 
grade 1 hepatic encephalopathy. LGHE has no or minimal recognizable symptoms but has mild cognitive and psycho-
motor deficits. Studies in Western countries have demonstrated increased road accidents (RA) among patients with 
MHE. Our objective was to investigate the association between Sri Lankan LGHE phenotype and RA.
Study design and methods: A prospective, case–control study was conducted in the University Medical Unit, North 
Colombo Teaching Hospital, Ragama Sri Lanka. Patients with cirrhosis of any aetiology, without OHE, who had been 
driving during previous 1 month were included. A similar number of age matched, healthy control drivers were also 
enrolled. Both groups were subjected to five pencil-paper based psychometric tests used to detect LGHE in cirrhotics. 
Self-reported RA during the previous 1 month were recorded: categorized as ‘major’ when resulted in hospitalization 
of the involved, ‘minor’ when there were injuries, but not serious enough for hospitalization of the involved and ‘other’ 
when limited to damages to vehicle or environment without injuries.
Results: Among 55 drivers with cirrhosis and LGHE [males, median age 53 years (range 30–60)], 7 (12.7 %) reported 
RA compared to 6 (10.9 %) among 55 controls [males; median age 51 years (range 30–60)]. There were no ‘major’ acci-
dents in either group. 2/55 (3.6 %) cases and 2/55 (3.6 %) controls reported ‘minor’ accidents.
Conclusion: There was no increased frequency of RA among Sri Lankan drivers with LGHE compared to healthy 
controls. This is with the limitation of the study based only on self reported RA.
Keywords: Driving, Road accidents, Cirrhosis, Low-grade hepatic encephalopathy, Minimal hepatic encephalopathy, 
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Background
Road accidents (RA) are the leading cause of hospital 
admissions in Sri Lanka [1]. Although a number of fac-
tors contribute to the occurrence of RA, human fac-
tors are one of the most cited causative influences [2, 3]. 
Minimal hepatic encephalopathy (MHE) is a complex 
neuro-psychological complication of cirrhosis, which 
is characterized by delayed reaction time and abnormal 
response inhibition [4–6]. MHE represents a part of the 
“low-grade” or “covert” hepatic encephalopathy (LGHE) 
in its mildest form. LGHE can be defined as the presence 
of test-dependent or clinical signs of brain dysfunction 
in patients with cirrhosis who are not disoriented or dis-
play asterixis. The term “minimal” conveys that there is 
no clinical sign, cognitive or other, of hepatic encepha-
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Clinically, patients with MHE and LGHE appear to 
be free of neuropsychiatric abnormalities, but exhibit 
specific, reversible, quantifiable neuropsychiatric and 
electroencephalographic abnormalities [8–11]. The prev-
alence of MHE in cirrhosis has been reported to vary 
from 30 to 84 %, depending on both the tests used and 
population studied [12, 13]. The diagnosis of MHE and 
LGHE is only through specialized neuro-psychometric 
or neuro-physiologic tests because there are no readily 
identifiable clinical manifestations [7, 14].
MHE and LGHE can have a significant impact on qual-
ity of life, ability to function in daily life and progression 
to overt hepatic encephalopathy (OHE) [15–17]. The 
ability to drive a car can be impaired in patients with 
MHE and it is a strong predictor of traffic violations and 
motor vehicle accidents in a self-reported setting [18]. 
However, studies on driving which largely relied upon 
the judgment of a designated driving instructor, showed 
conflicting results. One study showed patients with cir-
rhosis had no significant differences in their performance 
on a simulator or during actual driving conditions when 
compared to matched controls. In this study, stable sub-
jects with cirrhosis and evidence of portal hypertension, 
portal-systemic shunting, abnormal neuropsychologi-
cal tests and no prior history of overt encephalopathy 
did not exhibit a major impairment in their fitness to 
drive [19]. Another study showed similar findings that 
the presence of MHE did not necessarily predict driv-
ing unfitness. However, despite significant driving defi-
cits, patients with overestimated their driving abilities. It 
also showed that computer-based testing cannot reliably 
predict driving fitness [20]. Conversely, another prospec-
tive controlled study revealed fitness to drive a car to be 
impaired in the setting of MHE [21]. Thus, it was recom-
mended that patients with liver cirrhosis be tested for 
MHE, informed in case of abnormal test results and pos-
sible therapy known to improve psychometric test be ini-
tiated among them if continuing to drive. Furthermore, 
patients with cirrhosis and MHE diagnosed using inhibi-
tory control test (ICT) have a significantly higher crash 
rate over the preceding year and on prospective follow-
up compared to patients without MHE [22].
These is limited data on this topic from the South 
Asian region. The objective of the present study was to 
investigate above association of possible increase of RA 
and suitability to continue to drive among a cohort of Sri 
Lankan drivers with cirrhosis and LGHE.
Methods
This was a case control study. Data was collected pro-
spectively. Taking into consideration the reported dif-
ference in the accident rate between those with and 
without MHE in the literature, our study was adequately 
powered to detected difference of 20  % of RA among 
patients with cirrhosis and LGHE compared to controls. 
Informed written consent was obtained from both case 
and controls prior to enrollment after thorough expla-
nation of the purpose and nature of the study. Fifty-five 
patients with cirrhosis and LGHE (MHE and grade 1 
hepatic encephalopathy), who were regularly driving, 
were recruited from the Gastroenterology Clinic, Uni-
versity Medical Unit, Colombo North Teaching Hospital, 
Ragama, Sri Lanka, during August 2013 to November 
2014, by convenience sampling. Fifty-five age and sex 
matched healthy drivers who were teetotalers were 
recruited as controls. All patients and controls who were 
recruited had a valid driving license issued from the 
Department of Motor Traffic, Sri Lanka.
The diagnosis of cirrhosis was based on clinical, bio-
chemical and ultrasonographic findings that were com-
patible with cirrhosis. Exclusion criteria were OHE or a 
history of OHE, recent history of alcohol intake (within 
the past 1 month), use of medications precipitating HE, 
history of hepatocellular carcinoma, organ failure, neu-
rological or psychiatric disorders, visual, hearing disor-
ders or myopathies that may influence ability to drive and 
complete the psychometric tests.
A questionnaire was completed by each driver. It 
included demographic data, alcohol intake (amount and 
type), residential area (rural/urban), education level, 
aetiology and duration of cirrhosis and history of cir-
rhotic complications in the past. Similarly, specific driv-
ing details were also recorded. It included whether the 
person has obtained a valid driving license from relevant 
authority and the duration, types of vehicles driven, 
average distance per week and average time duration of 
driving per day. Self-reported RA during the previous 
1 month were recorded and were categorized. Accidents 
were considered as ‘major’ when the injured person/s 
involved needed hospital admission, and as ‘minor’ when 
the injured person/s involved did not require hospital 
admission. Accidents were categorized as ‘other’ when 
there were no injuries to person/s but included damage 
to the vehicle or the environment. Basic haematological 
and biochemical investigation results were also recorded 
in order to determine child-turcott-pugh (CTP) class and 
the MELD scores.
A standard psychometric test battery [number con-
nection test A and B (NCT A and B)], line tracing test 
(LTT), digit symbol test (DST) and serial dotting test 
(SDT)] was administered to both patients and controls 
by trained research assistants and the time to complete 
NCT A and B and SDT tests including error correction 
times were recorded. In DST, subjects were asked to sub-
stitute the symbols to 80 numbers as in the standard test 
in 90 s and the number of properly substituted numbers 
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were measured. In LTT, time taken for completion of the 
test and number of errors were recorded.
Before administering the above psychometric testing to 
cirrhotic drivers, their mental state was assessed by using a 
validated Sri Lankan version of Montreal cognitive assess-
ment scale (MOCA) [23]. An initial demonstration was 
performed for each participant so as to be familiar with the 
test. A longer time to complete each test with error correc-
tion was considered a poor test performance in NCT A/B, 
SDT and LTT. Additionally, number of errors also taken 
into account in LTT. Number of correctly substituted sym-
bols within 90 s was taken in DST; a performance impaired 
beyond 2 standard deviations (2SD) of the control perfor-
mance towards the pathological direction in any 3 or more 
tests was considered as diagnostic of LGHE.
Ethical approval for the study was obtained from the 
Ethics Review Committee, Faculty of Medicine, Univer-
sity of kelaniya, Ragama, Sri Lanka.
Results
Patients and controls are very well adjusted with regard 
to age, sex, education, residence and driving details. Fifty-
five cirrhotic patients with LGHE and 55 age and sex 
matched controls who were teetotalers were recruited. 
They were all males as only male cirrhotic drivers with 
LGHE could be identified at screening. The demographic 
characteristics and the types of accidents of the studied 
groups are shown in Table 1. Majority (n = 45, 82 %) of 
the patients were in 51–60 years of age. Therefore in the 
whole group, the normal reference ranges/means for the 
psychometric tests were almost similar to the values of 
51–60 years group.
None of 110 persons in the study had evidence of cog-
nitive impairment, and all had a score of more than 25 in 
the Sri Lankan version of the MOCA. The clinical and 
biochemical characteristics of the cirrhotic group are 
demonstrated in Table  2. 54.5  % of patients had cryp-
togenic cirrhosis and 56.3  % were categorized as Child 
class A. The presence of gastro-oesophageal varices was 
the only complication encountered in the MHE group 
(40 %). The findings of individual psychometric tests are 
given in Table  3. Apart from the LTT, which is a rela-
tively easy test to perform with minimal errors and error 
correction time, the performance in all other tests was 
significantly impaired in the LGHE group compared to 
controls.
Among 55 cirrhotic drivers with LGHE, 7 (12.7  %) 
reported accidents compared to 6 (10.9 %) among the 55 
controls (p 0.38; Chi square test). There were no ‘major’ 
accidents in either group. 2/55 (3.6  %) cases and 2/55 
(3.6 %) controls reported ‘minor’ accidents (p 0.69; Fish-
er’s exact test). The two minor accidents in each group 
had resulted in mild abrasions. ‘Other’ accidents were 
various types of events causing some damage to the vehi-
cle or environment.
Discussion
Impaired attention, visuo-motor coordination, psycho-
motor speed and response inhibition among patients 
with cirrhosis and MHE or LGHE may explain the pre-
viously reported increased incidence of RA [24]. How-
ever, the present study failed to demonstrate increased 
RA among a cohort of Sri Lankan drivers with cirrhosis 
and LGHE compared to an age matched healthy control 
group. Our finding is at variance with the findings of 
some studies conducted in Western countries.
In a previous study, patients with MHE had impaired 
driving skills and possible association of MHE with 
motor vehicle crashes [22]. That study used standard 






Age (mean years ± SD) 51.4 ± 8.4 49.5 ± 7.5
 30–40 years 3 3
 41–50 years 7 7
 51–60 years 45 45
Level of education
 <Grade 10 21 19
 Secondary 24 23
 Tertiary/university 10 13
Residence
 Urban 43 45
 Rural 12 10
Duration of the license
 <5 years 08 10
 5–10 years 21 20
 >10 years 26 25
Types of vehicles
 Bicycles/motor bikes 15 16
 Cars/vans 20 22
 Passenger services 08 10
 Mixed 12 07
Distance of driving per week
 <50 km 28 29
 >50 km 27 26
Duration of driving per day
 <1 h 19 20
 >1 h 36 35
Types of accidents
 With people 2 2
 With another vehicle 3 3
 With environment 2 1
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psychometric tests (SPT) or inhibitory control test 
(ICT) to diagnose MHE. A significantly higher propor-
tion of MHE patients diagnosed using ICT had motor 
vehicle crashes over the preceding year compared to 
those without MHE (17 vs. 0 %). Interestingly, SPT did 
not differentiate between those with/without a history 
of crashes [22]. Furthermore, patients with MHE fol-
lowed up prospectively were found to have significant 
future violations and crashes compared to those with-
out MHE (22 vs. 7  %). This finding was also observed 
only in the MHE group diagnosed using ICT [25]. 
Another study demonstrated that cirrhotics with MHE 
had slightly higher traffic violations and accidents (21 
vs. 17  % within 1  year and 36 vs. 33  % within 5  years 
respectively) compared to those without MHE [18]. 
Studies using on-road driving tests have demonstrated 
that MHE patients have significant defects in reac-
tion time, car handling, adaptation, cautiousness and 
maneuvering [21, 25]. Defects in navigation skills and a 
higher rate of illegal turns in such patients render them 
unsafe drivers [26, 27].
Therefore, from the available evidence from Western 
studies, a diagnosis of MHE or LGHE does not automati-
cally mean that the affected subject is a dangerous driver 
[7, 28]. Medical providers are not trained to formally 
evaluate fitness to drive. However, doctors cannot evade 
the responsibility of counseling patients with LGHE on 
the possible dangerous consequences of their driving. 
The safest advice is to stop driving until the responsible 
driving authorities have formally cleared the patient for 
safe driving [7].
Among the specialized tests to detect MHE or LGHE, 
neurophysiological tests such as critical flicker frequency 
(CFF) is fast and easy to administer and is recommended 
by some [28]. However, in Sri Lanka only psychomet-
ric tests can be performed in epidemiological studies at 
present since neurophysiological tests such as CFF is not 
readily available in clinical practice.
The Porto-Systemic Encephalopathy syndrome test 
(PSE-syndrome test) used by Weissenborn et  al., has 
Table 2 Clinical and biochemical characteristics of the cir-
rhotic (LGHE) group
SBP spontaneous bacterial peritonitis, OHE overt hepatic encephalopathy, HRS 
hepato- renal syndrome, AKI acute kidney injury, HCC hepatocellular carcinoma, 









 Child A 31
 Child B 18
 Child C 06
Duration since diagnosis of cirrhosis
 <1 month 27
 1–3 months 20





 Porto-systemic shunts None
 HRS/AKI None
 HCC None
Sodium (mmol/l) 136.9 ± 3.9
Potassium (mmol/l) 4.7 ± 4.9
ALT (IU/l) 54.6 ± 35.1
AST (IU/l) 69.5 ± 41.5
Albumin (g/l) 3.5 ± 0.6
Bilirubin (mg/dl) 1.4 ± 0.8
INR 1.7 ± 0.35
Haemoglobin (g/dl) 11.2 ± 2.1
Platelet count 105 ± 41
Creatinine (mg/dl) 1.1 ± 0.3
Table 3 Outcome of psychometric tests
Italics indicate statistically significant P value
NCT number connection test, SDT serial dotting test, LTT line tracing test, DST 
digit symbol test, LGHE low-grade hepatic encephalopathy
* Chi square test of significance
Psychometric test Mean Standard deviation P value*
NCT-A
 LGHE 83.76 15.85 <0.001
 Controls 57.60 12.28
NCT-B
 LGHE 243.02 57.99 <0.001
 Controls 89.33 13.74
SDT
 LGHE 82.62 10.96 <0.001
 Controls 58.75 6.46
LTT
 LGHE
  Time for completion 80.84 11.08 0.59
  Number of errors 7.23 4.21 0.49
Controls
 Time for completion 82.29 17.21
 Number of errors 6.41 4.01
DST
 LGHE 34.28 17.85 <0.001
 Controls 67.25 8.25
Page 5 of 6Subasinghe et al. BMC Res Notes  (2016) 9:303 
been validated for MHE diagnosis in Germany, Italy 
and Spain [14]. This test is recommended for diagnos-
ing MHE and provides the PHES (psychometric hepatic 
encephalopathy score). However, this has not been vali-
dated for the other countries including Sri Lanka. There-
fore, we decided to use our own criteria to detect MHE.
Absence of female cirrhotic drivers participation for 
this study is a major drawback and this is mainly due 
to the cultural background and overall low number of 
female drivers compared to the males in the country. 
After assurance of no impact on current driving license, 
irrespective of the test result outcome, none of the par-
ticipants declined to participate. The study was only 
based on self-reported RA. This was a limitation of our 
study. We considered RA during a relatively short period 
(previous 1 month) in order to minimize the events pos-
sibly forgotten.
The present study failed to show an increase in the inci-
dence of RA in a cohort of Sri Lankan drivers with cir-
rhosis and LGHE compared to healthy controls. Our 
study was adequately powered to detected difference of 
20 % of RA among LGHE patients compared to controls. 
The absence of driving or riding on high speed motor-
ways may at least partly explain this lack of increased RA 
in the study group. Computer based ICT, driving stimu-
lation tests and on-road driving tests could be used in a 
large cohort to further evaluate LGHE and its impact on 
driving. If such tests also fail to demonstrate impairment 
of driving skills, this will validate the findings of the pre-
sent study. Furthermore, the finding of this study has to be 
interpreted with the limitation of the short period of self-
reported RA among the Sri Lankan LGHE phenotype.
In conclusion, the findings of this study suggest that 
driving may be safe among patients with LGHE, but 
without OHE. Although our finding should be consid-
ered in a local (Sri Lankan) context, it will have practical 
implications with regards to advice on driving, holding a 
valid driving license and continuing to drive for patients 
with cirrhosis and LGHE.
Abbreviations
RA: road accidents; MHE: minimal hepatic encephalopathy; LGHE: low-grade 
hepatic encephalopathy; OHE: overt hepatic encephalopathy; ICT: inhibitory 
control test; CTP: child-turcott-pugh; NCT A and B: number connection test 
A and B; LTT: line tracing test; DST: digit symbol test; SDT: serial dotting test; 
MOCA: Montreal cognitive assessment scale; SPT: standard psychometric tests; 
ICT: inhibitory control test.
Authors’ contributions
Study concept and design: APDS, MAN, AD, SKCES, HJDS. Acquisition of 
data: SKCES, YN, SR. Statistical analysis: JKNDM, YN, SKCES. Interpretation of 
data: HJDS, APDS, MAN, AD, SKCES. Drafting of manuscript: SKCES, MAN, 
APDS, HJDS. Critical revision: HJDS, APDS, MAN, SKCES. All authors read and 
approved the final manuscript.
Author details
1 Professorial Medical Unit, North Colombo Teaching Hospital, Ragama, Sri 
Lanka. 2 Department of Medicine, Faculty of Medicine, University of Kelaniya, 
Thalagolla Road, PO Box 6, Ragama GQ 11010, Sri Lanka. 3 Department of Phar-
macology, Faculty of Medicine, University of Kelaniya, Ragama, Sri Lanka. 
Availability of supporting data
Data sets will not be freely available unless a valid request of research interest 
since it involves the personal details of the participants.
Competing interests
The authors declare that they have no competing interests.
Financial support
Department of Medicine, Faculty of Medicine, University of Kelaniya has 
supported the research material printing; no external source of funding was 
obtained.
Received: 22 December 2015   Accepted: 31 May 2016
References
 1. Annual Health Bulletin Sri Lanka. Sri Lanka: Statistics Unit of the Ministry 
of Health; 2012. vol. 26. http://www.health.gov.lk/en/publication/AHB-
2012/Annual%20Health%20Bulletin%20-%202012.pdf
 2. Evans L. The dominant role of driver behavior in traffic safety. Am J Publ 
Health. 1996;86:784–6.
 3. Petridou E, Moustaki M. Human factors in the causation of road traffic 
crashes. Eur J Epidemiol. 2000;16:819–26.
 4. Weissenborn K, Giewekemeyer K, Heidenreich S, et al. Attention, memory, 
and cognitive function in hepatic encephalopathy. Metab Brain Dis. 
2005;20:359–67.
 5. Schiff S, Vallesi A, Mapelli D, et al. Impairment of response inhibition 
precedes motor alteration in the early stage of liver cirrhosis: a behavioral 
and electrophysiological study. Metab Brain Dis. 2005;20:381–92.
 6. Weissenborn K, Heidenreich S, Ennen J, et al. Attention deficits in minimal 
hepatic encephalopathy. Metab Brain Dis. 2001;16:13–9.
 7. Vilstrup H, Amodio P, Bajaj J, et al. Hepatic encephalopathy in chronic 
liver disease: 2014 practice guideline by the American Association for the 
study of liver diseases and the European Association for the study of the 
liver. Hepatology. 2014;60(2):715–35.
 8. Ferenci P, Lockwood A, Mullen K, et al. Hepatic encephalopathy—defi-
nition, nomenclature, diagnosis and quantification: final report of the 
working party at the 11th world congresses of gastroenterology, Vienna, 
1998. Hepatology. 2002;35(3):716–21.
 9. Nie YQ, Li YY, Sha WH, Zeng Z, et al. Prevalence of subclinical hepatic 
encephalopathy in patients with cirrhosis determined by psychometric 
tests. Chin J Dig Dis. 2002;3(4):145–9.
 10. Rikkers L, Jenko P, Rudman D, Freides D. Subclinical hepatic encepha-
lopathy: detection, prevalence and relationship to nitrogen metabolism. 
Gastroenterology. 1978;75:462–9.
 11. Watanabe A, Sakai T, Sato S, Imai F, Ohto M, Arakawa Y, Toda G, Kobayashi 
K, Muto Y, Tsujii T, Kawasaki H, Okita K. Clinical efficacy of lactulose in 
cirrhotic patients with and without subclinical hepatic encephalopathy. 
Hepatology. 1997;26:1410–4.
 12. Schomerus H, Schreiegg J. Prevalence of latent portosystemic encepha-
lopathy in an unselected population of patients with liver cirrhosis in 
general practice. Z Gastroenterol. 1993;31(4):231–4.
 13. Mina A, Moran S, Ortiz-Olvera N, Mera R, Uribe M. Prevalence of minimal 
hepatic encephalopathy and quality of life in patients with decompen-
sated cirrhosis. Hepatol Res. 2014;44:E92–9.
 14. Weissenborn K, Ennen JC, Schomerus H, et al. Neuropsychological char-
acterization of hepatic encephalopathy. J Hepatol. 2001;34:768–73.
 15. Hartmann IJ, Groeneweg M, Quero JC, Beijeman SJ, de Man RA, Hop WC, 
Schalm SW. The prognostic significance of subclinical hepatic encepha-
lopathy. Am J Gastroenterol. 2000;95:2029–34.
Page 6 of 6Subasinghe et al. BMC Res Notes  (2016) 9:303 
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
 16. Romero-Gomez M, Boza F, Garcia-Valdecasas MS, Garcia E, Aguilar-Reina 
J. Subclinical hepatic encephalopathy predicts the development of overt 
hepatic encephalopathy. Am J Gastroenterol. 2001;96:2718–23.
 17. Groeneweg M, Quero JC, De Bruijn I, Hartmann IJ, Essink-bot ML, Hop WC, 
Schalm SW. Subclinical hepatic encephalopathy impairs daily function-
ing. Hepatology. 1998;28:45–9.
 18. Bajaj JS, Hafeezullah M, Hoffmann RG, et al. Minimal hepatic encepha-
lopathy: a vehicle for accidents and traffic violations. Am J Gastroenterol. 
2007;102:1903–9.
 19. Srivastava A, Mehta R, Rothke SP, et al. Fitness to drive in patients with 
cirrhosis and portal-systemic shunting: a pilot study evaluating driving 
performance. J Hepatol. 1994;21(6):1023–8.
 20. Kircheis G, Knoche A, Hilger N, et al. Hepatic encephalopathy and fitness 
to drive. Gastroenterology. 2009;137(1706–15):e9.
 21. Wein C, Koch H, Popp B, et al. Minimal hepatic encephalopathy impairs 
fitness to drive. Hepatology. 2004;39:739–45.
 22. Bajaj JS, Saeian K, Schubert CM, et al. Minimal hepatic encephalopathy is 
associated with motor vehicle crashes: the reality beyond the driving test. 
Hepatology. 2009;50(4):1175–83. doi:10.1002/hep.23128.
 23. Karunaratne S, Hanwella R, de Silva V. Validation of the Sinhala version 
of the Montreal cognitive assessment in screening for dementia. Ceylon 
Med J. 2011;56:147–53.
 24. Ortiz M, Jacas C, Co´rdoba J. Minimal hepatic encephalopathy: diagnosis, 
clinical significance and recommendations. J Hepatol. 2005;42(Suppl. 
1):S45–53.
 25. Watanabe A, Tuchida T, Yata Y, et al. Evaluation of neuropsychological 
function in patients with liver cirrhosis with special reference to their driv-
ing ability. Metab Brain Dis. 1995;10(3):239–47.
 26. Maguire EA, Burgess N, Donnett JG, et al. Knowing where and getting 
there: a human navigation network. Science. 1998;280(5365):921–4.
 27. Bajaj JS, Hafeezullah M, Hoffmann RG, et al. Navigation skill impairment: 
another dimension of the driving difficulties in minimal hepatic encepha-
lopathy. Hepatology. 2008;47(2):596–604.
 28. Ampuero J, Simon M, Montoliu C, et al. Minimal hepatic encepha-
lopathy and critical flicker frequency are associated with survival of 
patients with cirrhosis. Gastroenterology. 2015;149(6):1483–9 (pii: 
S0016-5085(15)01176).
